Sourced from authentic sources

This is the Phase I of the company’s Project Sanjeevani. SMT, which is India’s first and largest stent manufacturing company with a market share of over 30 per cent, is investing Rs 530 crore in the project

Hyderabad Pharma City, marked out by scuffed sign posts and a rubble-strewn access road is expected to attract about $8.4 billion and employ 560,000 people in hundreds of sprawling plants

he rental market is likely to gain momentum across major metro cities including Hyderabad, thanks to aggressive immunisation that has resulted in over a billion people being vaccinated.

Speaking on the occasion, KTR informed that the factory has already employed 900 people directly and ninety percent of those employed are from the constituency of Maheshwaram.

Alliance Group and Urbanrise announced that the company has clocked sales worth Rs 2,290 crore during the FY 2021-22. The company has sold 3,686 homes during the year.

IT Minister KT Rama Rao on Tuesday inaugurated the 1st facility of Jamp Pharmaceuticals Pvt Ltd outside Canada in Genome Valley.

Huge demand-supply mismatch in independent houses and plots, and price bands of Rs 60-100 lakh and Rs1-3 crore, shows data by Square Yards

Hyderabad recorded sales of 13,140 units in Q1 2022, a massive spike of 199 per cent over Q1 2021 - mainly due to continuous flow of new supply in the city over the past 5-6 quarters.

Telangana industries & IT minister KT Rama Rao, who is on a week-long US trip hard-selling Telangana as an investment destination, met top honchos of the world’s top three pharma players — Pfizer, Johnson & Johnson and GlaxoSmithKline

Minister urges ITServe Alliance member firms to become partners in State’s progress

As part of his US visit, Telangana industries & IT minister KT Rama Rao met the leadership team of the globally renowned Scripps Research Institute and held parleys on the proposed partnership between the Telangana government and the institute for the proposed Pharma University at the Hyderabad Pharma City.

Contract research organisation Chemveda Life Sciences will expand its footprint in Hyderabad by setting up a research and development centre with around ₹150 crore ($20 million).